Sepsis Induces Prolonged Epigenetic Modifications in Bone Marrow and Peripheral Macrophages Impairing Inflammation and Wound Healing.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
11 2019
Historique:
entrez: 24 10 2019
pubmed: 24 10 2019
medline: 9 4 2020
Statut: ppublish

Résumé

Sepsis represents an acute life-threatening disorder resulting from a dysregulated host response. For patients who survive sepsis, there remains long-term consequences, including impaired inflammation, as a result of profound immunosuppression. The mechanisms involved in this long-lasting deficient immune response are poorly defined. Approach and Results: Sepsis was induced using the murine model of cecal ligation and puncture. Following a full recovery period from sepsis physiology, mice were subjected to our wound healing model and wound macrophages (CD11b+, CD3-, CD19-, Ly6G-) were sorted. Post-sepsis mice demonstrated impaired wound healing and decreased reepithelization in comparison to controls. Further, post-sepsis bone marrow-derived macrophages and wound macrophages exhibited decreased expression of inflammatory cytokines vital for wound repair (IL [interleukin]-1β, IL-12, and IL-23). To evaluate if decreased inflammatory gene expression was secondary to epigenetic modification, we conducted chromatin immunoprecipitation on post-sepsis bone marrow-derived macrophages and wound macrophages. This demonstrated decreased expression of These data demonstrate that severe sepsis induces stable mixed-lineage leukemia 1-mediated epigenetic modifications in the bone marrow, which are passed to peripheral macrophages resulting in impaired macrophage function and deficient wound healing persisting long after sepsis recovery.

Identifiants

pubmed: 31644352
doi: 10.1161/ATVBAHA.119.312754
pmc: PMC6818743
mid: NIHMS1538038
doi:

Substances chimiques

Cytokines 0
Histones 0
NF-kappa B 0
histone H3 trimethyl Lys4 0
Myeloid-Lymphoid Leukemia Protein 149025-06-9
Histone-Lysine N-Methyltransferase EC 2.1.1.43
Kmt2a protein, mouse EC 2.1.1.43

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2353-2366

Subventions

Organisme : NIDDK NIH HHS
ID : U01 DK119083
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL137919
Pays : United States
Organisme : NIDDK NIH HHS
ID : F32 DK117545
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL031237
Pays : United States
Organisme : NIDDK NIH HHS
ID : P30 DK020572
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Arterioscler Thromb Vasc Biol. 2018 May;38(5):1102-1114
pubmed: 29496661
Lancet Infect Dis. 2013 Mar;13(3):260-8
pubmed: 23427891
Am J Respir Crit Care Med. 2013 Jun 15;187(12):1287-93
pubmed: 23590272
Clin Immunol. 2014 Dec;155(2):213-9
pubmed: 25451159
Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):292-303
pubmed: 29301789
Curr Diab Rep. 2018 Jan 23;18(1):2
pubmed: 29362914
Nat Rev Immunol. 2013 Dec;13(12):862-74
pubmed: 24232462
Wound Repair Regen. 2007 Sep-Oct;15 Suppl 1:S18-26
pubmed: 17727462
Expert Rev Mol Med. 2011 Jul 11;13:e23
pubmed: 21740602
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
PLoS One. 2013 Oct 21;8(10):e78045
pubmed: 24205083
Blood. 2008 Feb 15;111(4):1797-804
pubmed: 18055863
PLoS One. 2018 Jun 19;13(6):e0198555
pubmed: 29920518
Intensive Care Med. 2006 Aug;32(8):1175-83
pubmed: 16741700
Am J Pathol. 2006 Jun;168(6):1940-50
pubmed: 16723709
Nature. 2007 May 24;447(7143):425-32
pubmed: 17522676
Curr Opin Genet Dev. 2005 Apr;15(2):163-76
pubmed: 15797199
J Immunol. 2017 Sep 1;199(5):1865-1874
pubmed: 28733487
Cell. 2016 Nov 17;167(5):1354-1368.e14
pubmed: 27863248
Diabetes. 2013 Jul;62(7):2579-87
pubmed: 23493576
J Leukoc Biol. 2015 Oct;98(4):601-13
pubmed: 26059830
Immunity. 2017 Jul 18;47(1):3-5
pubmed: 28723551
Diabetes. 2017 Sep;66(9):2459-2471
pubmed: 28663191
Blood. 2009 Oct 8;114(15):3244-54
pubmed: 19567879
Crit Care Med. 2015 Apr;43(4):729-37
pubmed: 25365724
J Surg Res. 2002 Feb;102(2):193-7
pubmed: 11796018
Stem Cells. 2004;22(5):812-22
pubmed: 15342945
PLoS One. 2010 Jun 16;5(6):e11145
pubmed: 20585389
J Immunol. 2019 Mar 15;202(6):1777-1785
pubmed: 30710046
Nat Cell Biol. 2001 May;3(5):E117-23
pubmed: 11331897
Mol Med Rep. 2016 Dec;14(6):5467-5474
pubmed: 27878270
Wound Repair Regen. 2016 Jul;24(4):613-29
pubmed: 27196106
Ann Am Thorac Soc. 2015 Jun;12(6):904-13
pubmed: 25751120
Curr Opin Genet Dev. 2004 Apr;14(2):155-64
pubmed: 15196462
JAMA. 2017 Oct 3;318(13):1241-1249
pubmed: 28903154
J Immunol. 2005 Jul 1;175(1):461-8
pubmed: 15972680
Am J Pathol. 2007 Apr;170(4):1178-91
pubmed: 17392158
Epigenetics. 2011 Mar;6(3):273-83
pubmed: 21048427
JAMA. 2019 May 28;321(20):2003-2017
pubmed: 31104070
PLoS One. 2014 Mar 11;9(3):e91574
pubmed: 24618995
Crit Care. 2006;10(5):233
pubmed: 17044947
Crit Care. 2009;13(3):R100
pubmed: 19552820
Clin Chest Med. 2016 Jun;37(2):367-80
pubmed: 27229651
JAMA. 2019 May 28;321(20):1981-1982
pubmed: 31104067
Front Immunol. 2018 Nov 19;9:2685
pubmed: 30510555
Surgery. 1987 Aug;102(2):306-12
pubmed: 3616918
Cell. 2018 Jan 11;172(1-2):176-190.e19
pubmed: 29328912
Trends Immunol. 2009 Oct;30(10):475-87
pubmed: 19781994
Lancet Respir Med. 2014 May;2(5):380-6
pubmed: 24740011
Intensive Care Med Exp. 2014 Dec;2(1):20
pubmed: 26215705
Cell. 2018 Jan 11;172(1-2):147-161.e12
pubmed: 29328910
Mol Cell Biol. 2009 Apr;29(7):1959-71
pubmed: 19158276
Lancet Respir Med. 2016 Apr;4(4):259-71
pubmed: 26917434
Nat Cell Biol. 2004 Jan;6(1):73-7
pubmed: 14661024
Exp Lung Res. 2008 Jun;34(5):263-75
pubmed: 18465404
Immunity. 2006 May;24(5):611-22
pubmed: 16713978
JAMA. 1997 Apr 2;277(13):1058-63
pubmed: 9091694
PLoS One. 2013 Sep 25;8(9):e73992
pubmed: 24086305
J Cell Sci. 2012 Sep 1;125(Pt 17):4058-66
pubmed: 22623725
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292
Oncogene. 2009 Apr 2;28(13):1626-38
pubmed: 19219072
Diabetes. 2015 Apr;64(4):1420-30
pubmed: 25368099
JAMA. 1995 Jul 26;274(4):338-45
pubmed: 7609265
Crit Care. 2016 Feb 29;20:93
pubmed: 27056672

Auteurs

Frank M Davis (FM)

From the Section of Vascular Surgery, Department of Surgery (F.M.D., A.D., A.D.J., A.S.K., A.T.O., W.J.M., K.A.G.), University of Michigan, Ann Arbor.

Matthew A Schaller (MA)

Division of Pulmonary, Critical Care, and Sleep Medicine, University of Florida, Gainesville (M.A.S.).

Aaron Dendekker (A)

From the Section of Vascular Surgery, Department of Surgery (F.M.D., A.D., A.D.J., A.S.K., A.T.O., W.J.M., K.A.G.), University of Michigan, Ann Arbor.

Amrita D Joshi (AD)

From the Section of Vascular Surgery, Department of Surgery (F.M.D., A.D., A.D.J., A.S.K., A.T.O., W.J.M., K.A.G.), University of Michigan, Ann Arbor.

Andrew S Kimball (AS)

From the Section of Vascular Surgery, Department of Surgery (F.M.D., A.D., A.D.J., A.S.K., A.T.O., W.J.M., K.A.G.), University of Michigan, Ann Arbor.

Holly Evanoff (H)

Department of Pathology (H.E., M.S., B.C., S.L.K.), University of Michigan, Ann Arbor.

Carol Wilke (C)

Department of Internal Medicine (C.W., B.B.M.), University of Michigan, Ann Arbor.

Andrea T Obi (AT)

From the Section of Vascular Surgery, Department of Surgery (F.M.D., A.D., A.D.J., A.S.K., A.T.O., W.J.M., K.A.G.), University of Michigan, Ann Arbor.

William J Melvin (WJ)

From the Section of Vascular Surgery, Department of Surgery (F.M.D., A.D., A.D.J., A.S.K., A.T.O., W.J.M., K.A.G.), University of Michigan, Ann Arbor.

Karen Cavassani (K)

Urological Oncology, Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA (K.C.).

Melissa Scola (M)

Department of Pathology (H.E., M.S., B.C., S.L.K.), University of Michigan, Ann Arbor.

Beau Carson (B)

Department of Pathology (H.E., M.S., B.C., S.L.K.), University of Michigan, Ann Arbor.

Stephanie Moser (S)

Department of Anesthesiology (S.M., M.E.), University of Michigan, Ann Arbor.

Victoria Blanc (V)

Biorepository Office of Research (V.B.), University of Michigan, Ann Arbor.

Milo Engoren (M)

Department of Anesthesiology (S.M., M.E.), University of Michigan, Ann Arbor.

Bethany B Moore (BB)

Department of Internal Medicine (C.W., B.B.M.), University of Michigan, Ann Arbor.
Department Microbiology and Immunology (B.B.M., K.A.G.), University of Michigan, Ann Arbor.

Steven L Kunkel (SL)

Department of Pathology (H.E., M.S., B.C., S.L.K.), University of Michigan, Ann Arbor.

Katherine A Gallagher (KA)

From the Section of Vascular Surgery, Department of Surgery (F.M.D., A.D., A.D.J., A.S.K., A.T.O., W.J.M., K.A.G.), University of Michigan, Ann Arbor.
Department Microbiology and Immunology (B.B.M., K.A.G.), University of Michigan, Ann Arbor.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH